This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

Used by asset managers around the world, our tools and services are invaluable resources for a wide range of professional investors, including equity analysts, hedge funds, quantitative analysts, and ...